Evidence map›Paper›PMID 39167047›Full record

ArticleJournal of the American Chemical Society2024

Total Synthesis of the Norcembranoid Scabrolide B and Its Transformation into Sinuscalide C, Ineleganolide, and Horiolide.

Davy S Lin, Georg Späth, Zhanchao Meng, Lianne H E Wieske, Christophe Farès, Alois Fürstner

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Asymmetric Total Synthesis of (+)-Ineleganolide.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Total Synthesis of Benthol A: Evidence for a Structure Revision.Journal of the American Chemical Society · 2026
    Article
  3. Article
  4. Marine natural products.Natural product reports · 2026
    Review
  5. Short, Enantioselective Total Synthesis of (+)-Ineleganolide.Journal of the American Chemical Society · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Davy S LinMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Georg SpäthMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Zhanchao MengMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Lianne H E WieskeMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.ORCID 0000-0003-4617-7605
Christophe FarèsMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Alois FürstnerMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.ORCID 0000-0003-0098-3417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It was recognized only recently that the sister norcembranoids scabrolides A and B have notably different carbotricyclic scaffolds. Therefore, our synthesis route leading to scabrolide A could not be extended to its sibling. Rather, a conceptually new approach had to be devised that relied on a challenging intramolecular alkenylation of a ketone to forge the congested central cycloheptene ring at the bridgehead enone site; the required cyclization precursor was attained by a lanthanide-catalyzed Mukaiyama-Michael addition. The dissonant 1,4-oxygenation pattern was then installed by allylic rearrangement/oxidation of the enone, followed by suprafacial 1,3-transposition. Synthetic scabrolide B was transformed into sinuscalide C by dehydration and into ineleganolide by base-mediated isomerization/oxa-Michael addition, which has potential biosynthetic implications; under basic conditions, the latter compound converts into horiolide by an intricate biomimetic cascade.

Identifiers

PMID39167047
PMCPMC11378282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.